Clarinex Approval Includes Commitments From Schering On Stability Tests
Executive Summary
FDA's approval documents for Schering-Plough's antihistamine Clarinex show that the agency accepted two post-marketing manufacturing commitments from Schering rather than further delay the approval of the antihistamine
You may also be interested in...
Schering NDAs Are Clear For Review Under FDA Consent Decree
Schering-Plough NDAs will not be subject to extra scrutiny under the GMP consent decree with FDA
Schering NDAs Are Clear For Review Under FDA Consent Decree
Schering-Plough NDAs will not be subject to extra scrutiny under the GMP consent decree with FDA
Schering GMP Criminal Investigation Continues After Consent Decree
Schering-Plough faces a potential criminal case regarding GMP violations after finalizing a consent agreement with FDA May 17